FdaApplication
ANDA 219057
Identifiers
- fda_app_no: ANDA219057
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2024-12-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POSACONAZOLE | POSACONAZOLE | 300MG/16.7ML (18MG/ML) | SOLUTION;INTRAVENOUS |
1 product